Host genetic determinants of neurological disease induced by Cas-Br-M murine leukemia virus

Journal of Virology
|January 1, 1985
PubMed

Insights

Cas-Br-M murine leukemia virus causes hind-limb paralysis in mice. Genetic factors influence disease onset, with latency being a semidominant trait controlled by multiple genes affecting viral replication.

Area of Science:

  • Virology
  • Immunogenetics
  • Neuroscience

Background:

  • Cas-Br-M is an ecotropic murine leukemia virus (MuLV) causing neurogenic hind-limb paralysis.
  • Its N-tropism affects replication in mice with the Fv-1n allele.

Purpose of the Study:

  • To investigate susceptibility to Cas-Br-M-induced neurological disease across different Fv-1n mouse strains.
  • To understand the genetic basis of disease latency.

Main Methods:

  • Inoculation of newborn mice (NFS, C3H, DBA/2, CBA, AKR, C58, NZB) with Cas-Br-M MuLV.
  • Observation for tremor and hind-limb paralysis development.
  • Genetic crosses between short-, intermediate-, and long-latency strains.

Main Results:

  • Three disease patterns observed: short (NFS, C3H), intermediate (DBA/2, CBA), and long/no disease (AKR, C58, NZB).
  • Latency traits were semidominant, controlled by multiple independently assorting loci.
  • Genes likely regulate viral replication rate and CNS viral gene product accumulation.

Conclusions:

  • Mouse strain genetics significantly impact susceptibility and latency of Cas-Br-M-induced neurological disease.
  • Multiple interacting genes control disease progression, influencing viral dynamics in the central nervous system.

Related Concept Videos